Who's Your #1?

  • Facebook
  • Twitter
  • LinkedIn
  • RSS
  • Email

Research

Top JDRF Research Highlights

JDRF Applauds Launch of New Low Glucose Suspend Technology

Medtronic Product ‘a First Step Toward an Artificial Pancreas
Washington, DC, September 27, 2013 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, today applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels fall below a predetermined threshold. This morning, Medtronic announced FDA approval of its MiniMed 530G with Enlite system (sold outside the United States as the Veo since 2009).
“This approval means people with type 1 diabetes will have access to technologies on par with the rest of the world,” said Jeffrey Brewer, president and CEO of JDRF. “We appreciate all that the FDA and Medtronic have done to bring this system to people with type 1 diabetes in the U.S., and look forward to working with researchers, regulators, and the private sector to accelerate the delivery of even more impactful improvements in technology to more effectively manage the disease.”
JDRF continues to work with Medtronic and other industry and academic partners on a series of advances that will one day lead to a fully automated, closed-loop system that can truly be called an artificial pancreas. On the way to that goal, approaches to preventing hypoglycemia and implementing fully closed-loop control overnight have been demonstrated to work in outpatient clinical trials funded by JDRF and the National Institutes of Health (NIH). JDRF is committed to continuing its efforts well beyond this meaningful first step in automation by working with the FDA and medical device companies to accelerate these life-improving, and in some cases lifesaving, technologies for people with T1D.

To view the September 2013 issue please click here

To view the spring 2013 issue please click here

To view the summer 2012 issue please click here

Interesting Article that was discussed at FY13 Annual JDRF SWO Board Meeting

New York Times
Some of My Best Friends Are Germs
Medicine used to be obsessed with eradicating the tiny bugs that live within us. Now we’re beginning to understand all the ways they keep us healthy.
http://nyti.ms/10XmoXx

Other Research Updates

 

 

Donations Needed!

Volunteers Needed!